Physician

George Beverly Winton, MD

According to 2025 Medicare claims, George Winton, MD (NPI: 1447253653) practices dermatology in the Johnson City, TN market, with the plurality of this provider's patient population coming from Washington, TN. This provider's primary affiliated billing organization is TRICITIES SKIN AND CANCER (NPI: 1295824415; TIN: 621822644) and primary practice location at 37604-3693.

Winton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 549 traditional Medicare patients, billed 10,441 HCPCS/CPT codes, and received $232,353 in Medicare payments. The top billing code was 12032 (Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm). Part D data shows 449 prescription claims across 229 beneficiaries totaling $22,665 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 34 records totaling $910. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $426,271 to $232,353. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $76,866 to $22,665. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$226K$451K2015 Medicare payment: $426,271 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $429,675 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $373,179 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $451,338 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $410,981 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $345,996 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $220,474 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $281,838 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $238,047 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $232,353 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,6777,006$426,271
20162,6486,908$429,675
20172,4976,196$373,179
20182,8917,424$451,338
20192,7677,114$410,981
20201,9465,862$345,996
20214473,065$220,474
20225034,385$281,838
20235208,076$238,047
202454910,441$232,353

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$46K$92K2015 Drug cost: $76,866 (USD; Tot_Drug_Cst)2016 Drug cost: $91,992 (USD; Tot_Drug_Cst)2017 Drug cost: $49,841 (USD; Tot_Drug_Cst)2018 Drug cost: $58,486 (USD; Tot_Drug_Cst)2019 Drug cost: $70,381 (USD; Tot_Drug_Cst)2020 Drug cost: $12,933 (USD; Tot_Drug_Cst)2021 Drug cost: $10,460 (USD; Tot_Drug_Cst)2022 Drug cost: $12,414 (USD; Tot_Drug_Cst)2023 Drug cost: $53,457 (USD; Tot_Drug_Cst)2024 Drug cost: $22,665 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015125193$76,866
2016158295$91,992
2017131281$49,841
2018137267$58,486
2019117252$70,381
2020108198$12,933
2021149290$10,460
2022205366$12,414
2023179324$53,457
2024229449$22,665

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
12032Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm95109$208
17110Destruction of skin growth, 1-14 growths196247$73
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more236327$56
11102Biopsy of related skin growth, first growth92102$50
17000Destruction of precancer skin growth, 1 growth105130$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate35927$1,458
FluocinonideFluocinonide27817$1,087
MupirocinMupirocin631,345$621
KetoconazoleKetoconazole391,099$560
ImiquimodImiquimod15530$516

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.34$910Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for George Beverly Winton, MD?

Tedicare shows public-source Medicare data for George Beverly Winton, MD (NPI 1447253653), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George Beverly Winton, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to George Beverly Winton, MD?

George Beverly Winton, MD is linked to TRICITIES SKIN AND CANCER (billing NPI 1295824415) in the available physician profile data.

Does George Beverly Winton, MD have Open Payments data?

George Beverly Winton, MD has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.